Microbot Medical Inc.
MBOT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000883975
No open-market purchases or sales by Microbot Medical Inc. insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $22.1M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Microbot Medical Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 27 | 25 | −2 |
| Shares | 741.3K | 702.8K | −38.5K (−5.2%) |
| Value | $4.65M | $3.60M | −$1.04M (−22.4%) |
New holders (3)
Institutions that held Microbot Medical Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parkside Financial Bank & Trust | 42 | $0 | 0.00% |
| Newbridge Financial Services Group, Inc. | 1 | $0 | 0.00% |
| CoreCap Advisors, LLC | 50 | $0 | 0.00% |
Sold out (5)
Institutions that held Microbot Medical Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Citadel Advisors LLC | 14,847 | $93.0K |
| Millennium Management LLC | 13,997 | $88.0K |
| Blueshift Asset Management, LLC | 12,841 | $81.0K |
| FMR LLC | 1 | $0 |
| Alaethes Wealth LLC | 1 | $0 |